Form EFFECT Nasus Pharma Ltd
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 11, 2026 4:15 P.M. |
| Form: | F-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nasus Pharma to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
- Dr. Sanjeev Goel, M.D., Founder of Peak Human, Introduces Two Free Digital Tools for Personalized Nutrition Tracking and Physician-Guided Care
- New Memoir is an Inspiring and Humor-Filled Journey of Cultural Adaptation, Vulnerability and Resilience About Surviving Extreme Realities of Arctic Living
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
